Sindrome.del.Ovario.Poliquistico

Insulinosensibilizantes 127
metformin modify ovarian responsiveness
during exogenous FSH ovulation
induction in normogonadotrophic anovulation?
A placebo-controlled doubleblind
assessment. Eur J Endocrinol.
2005 Apr;152(4):611-7.
52
Ehrmann DA, Barnes RB, Rosenfield RL,
Cavaghan MK, Imperial J. Prevalence of
impaired glucose tolerance and diabetes
in women with polycystic ovary syndrome.
Diabetes Care. 1999;22:141-6.
53
Morin-Papunen LC, Koivunen RM,
Ruokonen A, Martikainen HK. Metformin
therapy improves the menstrual
pattern with minimal endocrine and
metabolic effects in women with polycystic
ovary syndrome. Fertil Steril.
1998;69:691-6.
54
Stadtmauer LA, Toma SK, Riehl RM,
Talbert LM. Metformin treatment of
patients with polycystic ovary syndrome
undergoing in vitro fertilization improves
outcomes and is associated with modulation
of the insulin-like growth factors.
Hum Reprod. 2001;17:3016-26.
55
Fedorcsák P, Dale PO, Storeng R, Abyholm
T, Tanbo T. The effect of metformin
on ovarian stimulation and in vitro
fertilization in insulin-resistant women
with polycystic ovary syndrome: an
open-label randomized cross-over trial.
Gynecol Endocrinol. 2003;17:207-14.
56
Jakubowicz DJ, Iuorno MJ, Jakubowicz
S, Roberts KA, Nestler JE. Effects
of metformin on early pregnancy loss
inthe polycystic ovary syndrome. J Clin
Edocrinol Metab. 2002;87:524-9.
57
Diamant YZ, Rimon E, Evron S. High
incidence of preeclamptic toxemia in
patients with polycystic ovarian disease.
Eur J Obstet Gynecol Reprod Biol. 1982;
14:199-204.
58
Mikola M, Hiilesmaa V, Halttunen M,
Suhonen L, Tiitiene A. Obstetric outcome
in women with polycystic ovarian
syndrome. Hum Reprod. 2001;16:226-9.
59
Radon PA, McMahon MJ, Meyer WR.
Impaired glucose tolerance in pregnat
women with polycystic ovaty syndrome.
Obstet Gynecol 1999;94:194-7.
60
Anttila L, Karjala K, Penttila RA, Ruutiainen
K, Ekblad U. Polycystic ovaries in
women with gestational diabetes. Obstet
Gynecol. 1998;92:13-6.
61
Kousta E, Cela E, Lawrence N, Penny A,
Millaurer B, White D, et al. The prevalence
of polycystic ovaries in women
with a history of gestational diabetes.
Clin Endocrinol (Oxf). 2000;53:501-7.
62
Hellmuth E, Damm P, Molsted Pedersen
L. Oral hypoglycaemica agents in 118
diabetic pregnancies. Diabet Med. 2000;
17:507-11.
63
Gris JC, Neuveu S, Mares P, Biron C,
Hedon B, Schved JF. Plasma fibrinolytic
activators and their inhibitors in women
suffering from early recurrent abortion
of unknown etiology. J Lab Clin Med.
1993;122:606-15.